Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
Healthcare
$13.31 +5.43%
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
52W Low $13.50High $25.93
Volume 0.21M
Average 0.38M
LTGO Pre-Tax Margin
Income before tax as a percentage of revenue.
No reported Pre-Tax Margin figures are available to summarize.
Pre-Tax Margin history
Percent of revenue · from the income statement
No Pre-Tax Margin data reported for this period type.
Pre-Tax Margin vs competitors
How LTGO compares with its peers on the latest reported figures
LTGO Competitors Peer median
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 13.6% | +3.8 pp | +18.1 pp | |
| LTM Mar 2026 | 1.8% | +11.5 pp | +0.3 pp | |
| LTM Mar 2026 | -1162.4% | -1015.4 pp | -1174.9 pp | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — |
| Peer median (excluding LTGO) | 1.8% | +3.8 pp | +0.3 pp | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Currency unavailable
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.